EMERGIS INC.
TSX : EME

DINMAR

DINMAR

November 16, 2006 14:35 ET

DINMAR Helps Regional and Provincial Efforts to Improve Access to Patient Data and Reduce Wait Times

Montfort Hospital Activates Oacis EMPI as Final Stage to Link Patient Records Across Eastern Ontario

OTTAWA, CANADA--(CCNMatthews - Nov. 16, 2006) - DINMAR, a wholly owned subsidiary of Emergis Inc. (TSX:EME), announced today that its Oacis EMPI (enterprise master patient index) application has been activated at Montfort Hospital as a final stage in linking patient records across Eastern Ontario. Oacis EMPI has been instrumental in significantly improving access to patient records throughout the Champlain Region's Local Health Integration Network (LHIN) in Eastern Ontario. In addition to speeding-up the patient identification process, Oacis EMPI contributes, as part of an array of projects currently underway, to reducing patient wait times.

The Oacis EMPI contains probabilistic matching technologies which continually inspect patient demographic information, from multiple sources, as it streams through Champlain's regional health network. The system compares key data elements and determines the probability that a particular patient record containing identical or similar elements is (or is not) the same as another patient record. Presently, the Oacis EMPI automatically matches an impressive 90% of records, thus saving significant time and costs for admissions and medical records personnel across a region compared to manual methods of identification. The remaining 10% of records are flagged as "suspects" whereby administrative personnel are alerted on-line to take appropriate follow-up action.

"Linking patient records is typically the first practical step towards the ultimate goal of a regional electronic health record system," commented Mark Groper, DINMAR's President and Chief Executive Officer and Senior Vice-President at Emergis. "This is in line with Emergis' mission to provide health care professionals with collaborative tools which enhance clinical decision-making, resulting in improved patient outcomes. Moreover, it demonstrates our company's unique ability to help sites, communities, regions, and provinces collectively provide better care."

The Champlain LHIN has rolled out the Oacis EMPI in stages across fifteen sites, with Ottawa-based Montfort Hospital in the final group. In addition to the EMPI project, Montfort engaged DINMAR to help the hospital implement the Province of Ontario's Wait Time Information System (WTIS) along with its linkage to the Province's EMPI through the Oacis EMPI.

"We are very enthusiastic about participating in such a worthwhile regional effort," said Gerald R. Savoie, President and Chief Executive Officer of Montfort Hospital. "The Oacis EMPI has already proved that linking patient records across broad geographic area helps clinical practitioners provide more rapid and safer care. It is important that Montfort Hospital contributes to this higher standard. Moreover, success within a region with significant English and French-speaking communities inspires great confidence within hospital staff, administrators and, more importantly, our clients and patients."

Oacis EMPI has a successful track record in other large-scale jurisdictions such as the State of South Australia, as well as in more focused integrated delivery networks (IDN) such as two university medical centres in Montreal, Quebec, and a large IDN in Dallas, Texas.

About Montfort Hospital

Montfort Hospital is a 189-bed community-oriented hospital which will double in size by the fall of 2009. The hospital is known across Canada and throughout the province of Ontario for its efficient operations and excellence in patient care and services. It plays a vital role in Ontario's Francophone community, providing health care in both official languages and serving as a Francophone teaching hospital. For more information, visit: www.hopitalmontfort.com.

About DINMAR

DINMAR, a wholly owned subsidiary of Emergis Inc., is a leading North American provider of health care information technology solutions. The Company provides a diverse array of professional services such as strategic planning, implementation services, change management, and custom software engineering in addition to its health care-specific commercial software applications. Based in Ottawa, Canada, the Company has regional branches in Toronto, Edmonton, Melbourne, and Northern California. For more information, visit www.dinmar.com.

About Emergis

Emergis, which acquired DINMAR in July 2006, is an IT leader that focuses on the health and financial services sectors. It develops and manages solutions that automate transactions and the exchange of information to increase the process efficiency and quality of service of its customers. Emergis has expertise in electronic health-related claims processing, health record systems, pharmacy management solutions, cash management and loan document processing and registration. In Canada, Emergis and its subsidiaries deliver solutions to the main insurance companies, top financial institutions, government agencies, hospitals, large corporations, real estate lawyers and notaries, and approximately 40% of all pharmacies. Emergis also processes and enables transactions for the world's leading payment associations. The Company's shares (TSX: EME) are included in the S&P/TSX Composite Index.

Certain information in this news release, in various filings with Canadian regulators, in reports to shareholders and in other communications, is forward-looking within the meaning of certain securities laws, and is subject to important risks, uncertainties and assumptions. This forward-looking information includes, among others, information with respect to the Company's objectives and the strategies to achieve those objectives, as well as information with respect to the Company's beliefs, plans, expectations, anticipations, estimates and intentions. The words "may", "could", "should", "would", "suspect", "outlook", "believe", "anticipate", "estimate", "expect", "intend", "plan", "target" and similar words and expressions are used to identify forward-looking information. The forward-looking information in this news release describes the Company's expectations as of November 16, 2006.

The results or events predicted in such forward-looking information may differ materially from actual results or events. Material factors which could cause actual results or events to differ materially from a conclusion, forecast or projection in such forward-looking information include, among others: general economic factors, adverse industry events, the adoption rate of the Company's solutions by customers and by related electronic trading communities, the non-renewal of major contracts which expire in the near term, complexities and the timing of signing government contracts, customers developing internally the capability to perform the services which the Company performs on their behalf, the Company's response to its industry's rapid rate of change, competition, pricing pressures, fluctuations in its operating results, its ability to make and integrate acquisitions, failures or material changes in its strategic relationships, exposure under contract indemnities, defects in software or failures in the processing of transactions, security or privacy breaches, the Company's ability to attract and retain key personnel, its ability to protect its intellectual property, intellectual property infringement claims, and industry and government regulation.

Emergis cautions that the foregoing list of material factors is not exhaustive. When relying on the Company's forward-looking information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. In making the forward-looking information contained in this news release, the Company does not assume any significant acquisitions, dispositions or one-time items. It does assume, however, the renewal of certain customer contracts. Every year, Emergis has major customer contracts that it needs to renew. Some of these may represent slightly more than 10% of its annual revenue. In addition, the Company also assumes the signature of contracts in new markets in the public health sector. In this regard, Emergis is pursuing large opportunities that present a very long and complex sales cycle, which substantially affect the Company's forecasting abilities. The Company has made certain assumptions regarding the timing of the realization of these opportunities which it thinks is reasonable but which may not be achieved. Furthermore, the pursuit of these larger opportunities does not ensure a linear progression of the Company's revenue and earnings, since they may involve significant up-front fees followed by reduced ongoing payments. The Company has assumed a certain progression, which may not be realized. It has also assumed that the material factors referred to in the previous paragraph will not result in such forward-looking information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. For additional information with respect to certain of these and other factors, refer to the risks and uncertainties section of the MD&A in the Company's 2005 Annual Report and to its 2005 Annual Information Form (risks and uncertainties) filed with Canadian regulators.

THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE EXPECTATIONS OF EMERGIS AS AT NOVEMBER 16, 2006 AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. HOWEVER, EMERGIS EXPRESSLY DISCLAIMS ANY INTENTION OR OBLIGATION TO UPDATE OR REVISE ANY FORWARD-LOOKING INFORMATION, WHETHER AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHERWISE, EXCEPT AS REQUIRED BY APPLICABLE LAW.

Contact Information